6-[(2E)-2-(3-bromo-4-methoxybenzylidene)hydrazinyl]-N-(4-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazin-5-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 6-[(2E)-2-(3-bromo-4-methoxybenzylidene)hydrazinyl]-N-(4-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazin-5-amine
• 英文别名: 5-N-[(E)-(3-bromo-4-methoxyphenyl)methylideneamino]-6-N-(4-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine
• 化学式: C₁₈H₁₃BrFN₇O₂
• 分子量: 458.2
• InChiKey: RFWQUJYTJRMAER-ZVBGSRNCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  110
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• Heterocyclic compounds as pharmaceutically active compounds
  申请人：Aulinger-Fuchs Katharina

  公开号：US20050143382A1

  公开（公告）日：2005-06-30

  The present invention relates to furazanopyrazine derivatives of the general formula (I): wherein: R′ represents —NR 1 R 2 or —OR 9 R″ represents —NR 5 —NR 3 R 4 , —NR 5 —OR b , —O—NR 3 R 4 ; wherein R 1 to R 9 in formula (I) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.

  本发明涉及通式(I)的呋嗪并吡嗪衍生物，其中：R′代表—NR1R2或—OR9；R″代表—NR5—NR3R4，—NR5—ORb，—O—NR3R4；在公式(I)中，R1至R9独立地代表多种不同的取代基，包括烷基、芳基、芳基烷基、烷基芳基、杂环芳基基团和单官能团。
• DISCOVERY OF NOVEL ANTICANCER COMPOUNDS BASED ON CONFORMATIONAL SAMPLING OF QUINOXALINHYDRAZIDE PHARMACOPHORE
  申请人：NEAMATI Nouri

  公开号：US20100160313A1

  公开（公告）日：2010-06-24

  The present invention relates in general to anti-cancer drug design. More specifically, the invention provides methods of mapping and screening for anti-cancer agents using pharmacophore models. The invention demonstrates that, conformational sampling of a small lead molecule, followed by representative pharmacophore model development, is an efficient approach for rational design of novel anticancer agents with similar or better potency than the original lead but with different physicochemical properties.
• US8445677B2
  申请人：——

  公开号：US8445677B2

  公开（公告）日：2013-05-21